Spectrum of infections occurring in patients of autoimmune rheumatic diseases on treatment with biological versus conventional disease-modifying antirheumatic drugs
Partisha Gupta, Prasanta Padhan, Nishant Bhargava, Pradip Kumar Behera, Krishna Padarabinda Tripathy, Sudhansu Sekhar Panda
Journal of Family Medicine and Primary Care, 2022
Abstract
This research paper explore the methodology and findings associated with Journal of Family Medicine and Primary Care. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).
- Use of biological disease modifying antirheumatic drugs in rheumatoid arthritis in Austria from 2008 to 2011 2018
- Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010 2018
- UTILIZATION PATTERNS OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES 2019
- [Therapy of rheumatic disease using a new antirheumatic drug]. 1974
- Profile of Patients with Rheumatoid Arthritis: a Descriptive Analysis 2022
- Glucocorticoid use, other associated factors, and the risk of tuberculosis 2006
- Anti–tumor necrosis factor α therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis 2007
- Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial 2012
- Risk of Hospitalized Bacterial Infections Associated With Biologic Treatment Among US Veterans With Rheumatoid Arthritis 2014
- Etanercept in the treatment of rheumatoid arthritis 2007